Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Q2 2023 Astellas Pharma Inc Earnings Presentation Transcript

Oct 31, 2022 / 07:00AM GMT
Release Date Price: $14.08 (+4.53%)

Oct 31, 2022 / 07:00AM GMT
Presentation
Oct 31, 2022 / 07:00AM GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Chairman of the Board
* Minoru Kikuoka
Astellas Pharma Inc. - CFO & Senior Managing Executive Officer
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot